Perrigo Company plc (PRGO)

33,06 +0,16 (+0,49 %) À la clôture : 04:00PM EDT

Perrigo Company plc

The Sharp Building
Hogan Place
Dublin D02 TY74
Ireland
353 1 709 4000
https://www.perrigo.com

Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein: 9 140

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Patrick Lockwood-Taylor	President, CEO & Director	2,37M	S.O.	S.O.
Mr. Eduardo Guarita Bezerra	Executive VP & CFO	1,2M	S.O.	1976
Mr. Ronald C. Janish	Chief Transformation Officer and Executive VP of Global Operations & Supply Chain	1,36M	S.O.	1966
Ms. Kyle L. Hanson	Executive VP, General Counsel & Corporate Secretary	943,95k	S.O.	1965
Mr. Svend Andersen	Executive VP & President of Consumer Self-Care International	1,11M	S.O.	1962
Mr. Shannon Hukill	Senior Director of Technical Operations	S.O.	S.O.	S.O.
Mr. Thomas M. Farrington	Chief Information Officer & Executive VP	S.O.	S.O.	1957
Ms. Alison Ives	Executive VP & Chief Scientific Officer	S.O.	S.O.	1981
Mr. Bradley Joseph	Vice President of Global Investor Relations & Corporate Communications	S.O.	S.O.	S.O.
Ms. Mary Reilly-Brest	Director of Global Organizational and Human Resource Development	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Perrigo Company plc en date du 1 mai 2024 est 1. Les scores principaux sont Audit : 5; Société : 1; Droits des actionnaires : 1; Compensation : 3.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.